Hausman Diana
- SEC CIK
- 0001563992
No open-market purchases or sales filed in the past year.
Current role at each company
- IMRX Immuneering CorpDirectoras of Jun 11, 2026
- ZNTL Zentalis Pharmaceuticals, Inc.Chief Medical Officeras of May 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hausman Diana as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMRX Immuneering Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 (view filing) | Jul 2 | 5 days | Hausman DianaDirector | PPurchaseClass A Common Stock | +2.50K | $3.60 | +$9.00K | New position2.50K after | |
| Jul 7, 2025 (view filing) | Jul 2 | 5 days | Hausman DianaDirector | PPurchaseClass A Common Stock | +3.00K | $3.62 | +$10.9K | New position3.00K after |
ZNTL Zentalis Pharmaceuticals, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2024 (view filing) | May 9 | Same day | Hausman DianaChief Medical Officer | SSale | −3.36K | $12.62 | −$42.4K | −0.9%373.9K after |